Alembic Pharmaceuticals is in the business of development, manufacturing, and marketing of Pharmaceuticals products i.e. Formulations and Active Pharmaceutical Ingredients.
The company has 3 R&D and 5 manufacturing facilities.
Financial Results:
Alembic Pharmaceuticals Ltd reported Revenues for Q1FY24 of ₹1,486.00 Crores up from ₹1,262.00 Crore year on year, a rise of 17.75%.
Total Expenses for Q1FY24 of ₹1,367.00 Crores up from ₹1,331.00 Crores year on year, a rise of 2.7%.
Consolidated Net Profit of ₹121.00 Crores from -₹66.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹6.14, from -₹3.35 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.